Geode Capital Management
OMED

Geode Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Geode Capital Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-197,855
Closed -$205K – 4305
2019
Q1 		$205K Buy
197,855
+24,292
+14% +$25.2K ﹤0.01% 3737
2018
Q4 		$129K Buy
173,563
+46,083
+36% +$34.3K ﹤0.01% 3813
2018
Q3 		$270K Buy
127,480
+10,150
+9% +$21.5K ﹤0.01% 3667
2018
Q2 		$271K Hold
117,330
– – ﹤0.01% 3638
2018
Q1 		$373K Hold
117,330
– – ﹤0.01% 3498
2017
Q4 		$481K Sell
117,330
-7,239
-6% -$29.7K ﹤0.01% 3370
2017
Q3 		$563K Hold
124,569
– – ﹤0.01% 3316
2017
Q2 		$414K Sell
124,569
-40,319
-24% -$134K ﹤0.01% 3423
2017
Q1 		$1.52M Sell
164,888
-1,075
-0.6% -$9.9K ﹤0.01% 2799
2016
Q4 		$1.28M Buy
165,963
+27,457
+20% +$211K ﹤0.01% 2876
2016
Q3 		$1.58M Buy
138,506
+31,524
+29% +$360K ﹤0.01% 2695
2016
Q2 		$1.32M Buy
106,982
+4,893
+5% +$60.2K ﹤0.01% 2747
2016
Q1 		$1.03K Sell
102,089
-73
-0.1% -$1 ﹤0.01% 2866
2015
Q4 		$2.3M Buy
102,162
+10,845
+12% +$244K ﹤0.01% 2386
2015
Q3 		$1.51M Sell
91,317
-2,873
-3% -$47.6K ﹤0.01% 2622
2015
Q2 		$2.12M Buy
94,190
+23,016
+32% +$518K ﹤0.01% 2464
2015
Q1 		$1.83M Buy
71,174
+2,147
+3% +$55.3K ﹤0.01% 2494
2014
Q4 		$1.5M Buy
69,027
+7,915
+13% +$172K ﹤0.01% 2604
2014
Q3 		$1.16M Buy
61,112
+24,431
+67% +$462K ﹤0.01% 2700
2014
Q2 		$854K Buy
36,681
+5,760
+19% +$134K ﹤0.01% 2889
2014
Q1 		$1.04M Buy
30,921
+1,399
+5% +$47.1K ﹤0.01% 2779
2013
Q4 		$871K Buy
29,522
+1,878
+7% +$55.4K ﹤0.01% 2802
2013
Q3 		$423K Buy
+27,644
New +$423K ﹤0.01% 3023